| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
|
N Engl J Med
|
2014
|
4.91
|
|
2
|
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
|
Clin Infect Dis
|
2009
|
3.05
|
|
3
|
Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
|
Clin Infect Dis
|
2008
|
2.87
|
|
4
|
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
|
AIDS
|
2011
|
2.43
|
|
5
|
Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda.
|
Ann Behav Med
|
2013
|
2.25
|
|
6
|
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
|
Clin Infect Dis
|
2013
|
2.02
|
|
7
|
Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda.
|
Soc Sci Med
|
2012
|
1.88
|
|
8
|
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.
|
Emerg Infect Dis
|
2014
|
1.55
|
|
9
|
GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.
|
AIDS
|
2013
|
1.46
|
|
10
|
Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.
|
PLoS One
|
2012
|
1.39
|
|
11
|
Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda.
|
J Acquir Immune Defic Syndr
|
2013
|
1.39
|
|
12
|
Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.
|
PLoS One
|
2013
|
1.29
|
|
13
|
How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda.
|
AIDS Behav
|
2013
|
1.21
|
|
14
|
Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.
|
Clin Infect Dis
|
2013
|
1.19
|
|
15
|
Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda.
|
AIDS
|
2013
|
1.14
|
|
16
|
Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
|
J Acquir Immune Defic Syndr
|
2014
|
1.07
|
|
17
|
The dynamic relationship between social support and HIV-related stigma in rural Uganda.
|
Ann Behav Med
|
2014
|
1.07
|
|
18
|
Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda.
|
AIDS Behav
|
2013
|
1.05
|
|
19
|
Optimizing network connectivity for mobile health technologies in sub-Saharan Africa.
|
PLoS One
|
2012
|
1.04
|
|
20
|
HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods.
|
AIDS
|
2013
|
1.02
|
|
21
|
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
|
Retrovirology
|
2013
|
1.01
|
|
22
|
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.
|
AIDS Res Hum Retroviruses
|
2014
|
0.92
|
|
23
|
Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda.
|
AIDS
|
2014
|
0.91
|
|
24
|
Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda.
|
PLoS One
|
2013
|
0.90
|
|
25
|
Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.
|
J Acquir Immune Defic Syndr
|
2014
|
0.88
|
|
26
|
No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda.
|
AIDS Behav
|
2013
|
0.81
|
|
27
|
Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards.
|
PLoS Med
|
2013
|
0.81
|
|
28
|
AIDS-related mycoses: the way forward.
|
Trends Microbiol
|
2014
|
0.80
|
|
29
|
Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring.
|
AIDS
|
2017
|
0.78
|
|
30
|
Handheld point-of-care cerebrospinal fluid lactate testing predicts bacterial meningitis in Uganda.
|
Am J Trop Med Hyg
|
2012
|
0.76
|
|
31
|
Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda.
|
AIDS
|
2016
|
0.75
|
|
32
|
Tobacco use among adults initiating treatment for HIV infection in rural Uganda.
|
AIDS Behav
|
2014
|
0.75
|
|
33
|
Should antiretroviral therapy be delayed for 10 weeks for patients treated with fluconazole for cryptococcal meningitis?
|
Clin Infect Dis
|
2010
|
0.75
|
|
34
|
Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches.
|
AIDS
|
2017
|
0.75
|